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Biﬁdobacterium longum 1714 as a translational psychobiotic:
modulation of stress, electrophysiology and neurocognition
in healthy volunteers
AP Allen1,2, W Hutch3,4, YE Borre1, PJ Kennedy1,2, A Temko5, G Boylan3,4, E Murphy6, JF Cryan1,7,8, TG Dinan1,2 and G Clarke1,2
The emerging concept of psychobiotics—live microorganisms with a potential mental health beneﬁt—represents a novel approach
for the management of stress-related conditions. The majority of studies have focused on animal models. Recent preclinical studies
have identiﬁed the B. longum 1714 strain as a putative psychobiotic with an impact on stress-related behaviors, physiology and
cognitive performance. Whether such preclinical effects could be translated to healthy human volunteers remains unknown. We tested
whether psychobiotic consumption could affect the stress response, cognition and brain activity patterns. In a within-participants
design, healthy volunteers (N= 22) completed cognitive assessments, resting electroencephalography and were exposed to a
socially evaluated cold pressor test at baseline, post-placebo and post-psychobiotic. Increases in cortisol output and subjective
anxiety in response to the socially evaluated cold pressor test were attenuated. Furthermore, daily reported stress was reduced by
psychobiotic consumption. We also observed subtle improvements in hippocampus-dependent visuospatial memory performance,
as well as enhanced frontal midline electroencephalographic mobility following psychobiotic consumption. These subtle but clear
beneﬁts are in line with the predicted impact from preclinical screening platforms. Our results indicate that consumption of
B. longum 1714 is associated with reduced stress and improved memory. Further studies are warranted to evaluate the beneﬁts
of this putative psychobiotic in relevant stress-related conditions and to unravel the mechanisms underlying such effects.
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INTRODUCTION
Recent years have seen growing research interest in the possibility
of targeting the gut microbiome to beneﬁcially impact on brain
and behavior. A promising strategy in this ﬁeld is that of
psychobiotics—live microorganisms that convey a beneﬁt upon
the host’s mental health when consumed in adequate quantities.1
There is increasing interest in the impact of putative psychobiotics
upon central nervous system processes, especially stress, mood,
anxiety and cognition.2,3 Preclinical research has indicated that
chronic probiotic administration can reduce anxiety-like and
depressive-like behavior, and can normalize associated physiolo-
gical outputs such as corticosterone, noradrenaline, brain-derived
neurotrophic factor and immune function.4–7
Although most of the evidence in this area comes from animal
studies, speciﬁc probiotic strains have shown potential for
symptom alleviation in irritable bowel syndrome (IBS),8,9 a stress-
related brain–gut axis disorder associated with high rates of
psychopathology10 as well as altered hypothalamic–pituitary–
adrenal axis activity11 and cognition.12,13 A number of encourag-
ing proof-of-principle studies in healthy human volunteers
have now demonstrated that multistrain probiotics, fermented
drinks containing probiotics or prebiotics can alter resting brain
activity, cognitive performance, baseline physiological stress
outputs and self-reported psychological variables.5,14–18 It is,
however, unclear whether the use of single putative psychobiotic
strains is also a viable approach in humans and whether a
discovery pipeline can be developed to inform superior candidate
strain selection as well as evaluation across a broader range of
relevant parameters.
We have recently proposed a precision strategy in the use of
psychobiotics for targeting stress-related central nervous system
disorders including anxiety and depression.1 The rational selection
of candidate strains identiﬁed in well-validated preclinical screen-
ing platforms is a more logical approach to guide the challenging
move toward clinically useful psychobiotics. Accordingly, in
preclinical studies, we have identiﬁed the Biﬁdobacterium longum
1714 strain, which selectively improves stress-related behaviours,
physiology and cognitive performance.19,20 The current study
investigated whether these preclinical effects could be translated
to healthy human volunteers.
We examined the effects of the 1714 strain compared with
placebo on daily reported stress and the psychobiological
response to an acute, controlled stressor.21,22 We also assessed
cognitive performance; in addition to our previous preclinical
ﬁndings indicating improved memory, there is existing evidence
that consumption of probiotics can affect performance on
sustained attention performance,18 as well as in brain activity
during social cognition.15 We thus assessed cognitive performance
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on tests assessing memory, sustained attention, social cognition
and emotional processing. We also assessed brain activity in
frontal, parietal and central regions using electroencephalography
(EEG) following 4-week supplementation with the 1714 strain in
comparison with placebo, as these regions have been associated
with memory and sustained attention23,24 and are sensitive to
anxiolytics.25
MATERIALS AND METHODS
The research described received approval from the Clinical Research Ethics
Committee of the Cork Teaching Hospitals (Protocol Number: APC044).
Informed consent was obtained from all participants, who were free to
withdraw from the study at any time.
Design
A repeated measures, placebo-controlled design was employed. A
repeated measures design was employed in order to exclude the effects
of individual differences across variables. Participants were screened at an
initial visit for psychiatric disorder using the MINI International Neuropsy-
chiatric Interview (MINI26), and demographic and baseline psychological
information was collected. Following screening, participants completed
neurocognitive visits and acute stress visits. Participants were then
administered placebo for four weeks followed by the 1714 strain for
four weeks, with the second and third set of visits following the placebo
and probiotic phases. Participants also completed a 2-week post-probiotic
follow-up. Participants ﬁlled in daily online questionnaires from the end of
the ﬁrst set of visits to the end of follow-up.
Participants
With a power of 0.8 for a one-way analysis of variance, a minimum sample
size of 20 was required to demonstrate an effect sized f=0.3 at α= 0.05.27
The study was completed by 22 healthy male volunteers (see Table 1 for
detailed participant characteristics). Male participants were selected to
avoid the need to control for menstrual cycle, which can impact upon
cortisol output and other readouts. Participants were aged between 18 and
40 years of age. Exclusion criteria were as follows: having a signiﬁcant
acute or chronic illness; having a condition, following a diet or taking a
medication that would interfere with study objectives, pose a safety risk or
confound the interpretation of the study results; evidence of immunode-
ﬁciency, bleeding disorder or coagulopathy; English not being participant’s
ﬁrst language; colour blindness, dyslexia or dyscalculia; smoking; self-
report habitually taking any probiotic products; receiving any treatment
involving experimental drugs (see Supplementary Figure 1 for recruitment
ﬂowchart).
Materials
Both placebo and probiotic sticks contained maltodextrin and magnesium
stearate; probiotic sticks additionally contained 1× 109 colony-forming
units per stick of the 1714 strain. Participants were instructed to take one
stick each morning by mixing the contents of the stick into milk and
drinking.
Self-report. Online questionnaires were completed each day: the Cohen
Perceived Stress Scale,28 and a question on whether participants had taken
their probiotic that day. Online questionnaires were administered using
limesurvey software.29
Cognitive tasks. Tests from the Cambridge Neuropsychological Test
Automated Battery (CANTAB30) were presented on a touch-screen monitor,
Sahara i440D Slate Tablet PC (Sand Dune Ventures, Tablet Kiosk, Torrance,
CA, USA) running CANTABeclipse software (Cambridge, UK). The researcher
provided verbal instructions to participants from a standardised script.
Tests were presented in different orders for different participants, using a
Latin square design, to avoid effects of fatigue for tests completed later in
the session. The test battery lasted ~ 45 min in total. The Paired Associate
Learning (PAL) test was used to assess conditional learning of pattern–
location associations. Paired associate learning performance has shown
sensitivity to functional changes in the hippocampus31 and frontal lobes.23
The parallel mode (which presents different shapes at each visit) was used
in order to avoid practice effects.
Rapid visual information processing was used to assess sustained
attention. Performance on this task activates a frontoparietal network of
brain regions,24 and a modiﬁed version of this task is sensitive to changes
in quantitative frontal EEG.32
Emotion Recognition Task was used to assess social cognition.
Functional magnetic resonance imaging has previously demonstrated
probiotic effects on a network of brain regions involved in emotional and
viscerosensory processing in healthy controls.15
In addition to tests from the CANTAB battery, we assessed emotional
processing using an Emotional Stroop.33 The Stroop test was presented on
the same high-resolution touch-screen monitor used with the CANTAB
battery. The emotional Stroop is associated with activation in the anterior
cingulate cortex.34,35 Positively, negatively and neutrally valenced words
were presented, matched for length in letters, orthographic neighbour-
hood size (that is, the number of words which differ from a given word by
only one letter) and frequency of use.36
We used an auditory oddball task to study the P300 event-related
potential, which has been shown to be sensitive to anxiolytic effects at the
cerebral electrode locations assessed in the current study.25 See
Supplementary Table 1 for detailed description of the cognitive tasks.
Neurocognitive assessment
Prior to EEG testing participants were asked to refrain from caffeine on the
morning of their experimental session, as well as ensuring they got a good
night’s sleep, to remove any piercings and avoid wearing hair gel. All EEG
measurements were made using a Neuroscan, SynAmps 2 Ampliﬁer and
Neuroscan 4.3.1 acquisition software (Compumedics, Abbotsford, VIC,
Australia). EEG data were recorded at a sampling rate of 1000 Hz. Scalp
electrodes were attached at midline positions Fz, Pz and Cz, according to
the international 10/20 system, as well as mastoid electrodes and a
reference electrode on the nose. Vertical eye movements were detected
using electrodes attached above and below the orbit of the left eye
and horizontal eye movements were monitored by electrodes at the right
and left outer canthi. Electrodes were applied to the scalp using soft paste
and secured using tape and an elasticated hat.
Following a resting EEG recording, the cognitive tasks were completed
(see Cognitive tasks). EEG was recorded continuously during performance
of the auditory oddball task, but was not measured during the other
cognitive tasks to avoid artefacts in the EEG readings.
Resting EEG
EEG measures of absolute power in the delta (1.5–3.5 Hz), theta (4–7.5 Hz),
alpha1 (8–9.5 Hz), alpha2 (10–12.5 Hz), beta1 (13–17.5 Hz) and beta2 (18–
25.5 Hz) frequency bands were taken for an initial ﬁve minute period with
eyes closed (based on Romano-Torres et al.37). Participants were requested
to relax and sit still with their eyes closed while resting EEG was recorded.
Resting EEG has been shown to be consistent across repeated visits,38 and
so should not be vulnerable to carryover effects.
Table 1. Participant characteristics
Age, years M= 25.5 (1.2)
BMI M= 24.8 (0.7)
Alcohol consumption (units per week) M= 7.5 (1.3)
Years of Education M= 18.6 (0.6)
Trait anxiety (STAI) M= 29.9 (1.7)
Depression (BDI) M= 3.6 (0.9)
Stress (CSS) M= 9 (1)
IQ (NART estimated) M= 107.5 (1.17)
Occupation Doctor, 3
Psychologist, 1
Fire service, 1
Sculptor, 1
Medical student, 5
Postgraduate student, 2
Student (other), 9
Abbreviations: BDI, Beck Depression Inventory52; BMI, body mass index;
CSS, Cohen Perceived Stress Scale28; IQ, intelligent quotient; M, mean;
NART, National Adult Reading Test53; STAI, State-Trait Anxiety Inventory40.
S.e.m. in parentheses.
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Acute stress procedure
We employed the socially evaluated cold pressor test (SECPT)21 as a
combined psychological and physiological stressor procedure, which has
been shown not to induce hypothalamic–pituitary–adrenal axis habituation
across repeated exposures.39 Participants were required to avoid alcohol for
24 h prior to the visit, as well as caffeinated beverages on the day of the
stress procedure and strenuous exercise from 1400 hours the day before,
and to fast for 2 h prior to testing. Pre-stress, the participant completed the
state items from the state-trait anxiety inventory,40 and a baseline saliva
sample was taken. The baseline measures were followed by a 5-min resting
phase. Following the 5-min resting phase, another saliva sample was taken.
The participant read the instructions for the SECPT and the experimenter
answered any questions. The participant then completed the SECPT (see
Supplementary Table 2 for full details). Following completion of the SECPT
the participant completed the post-stress state anxiety questionnaire.
Further saliva samples were taken 1 min after the cessation of the stressor,
as well as 10, 20, 30, and 60 min post-stressor cessation.
Analysis
EEG analysis
Resting EEG, frequency domain: Data were examined for eyeblink
artefacts. After correction for eyeblinks, data were epoched, with an epoch
duration of 2 s. A linear detrend based on the entire sweep was applied to
the epoched ﬁle, which was then baseline corrected for the pre-stimulus
interval. A band pass ﬁlter (0.1–35 Hz, IIR, 24 dB/octave) was applied.
Following a further visual inspection for artefacts and baseline correction
the epochs were averaged. Multiplication of data by a 25% cosine window
was applied, as this has been used previously in examining anxiolytic
effects.41 EEG measures of absolute power were extracted in the delta
(1.5–3.5 Hz), theta (4–7.5 Hz), alpha1 (8–9.5 Hz), alpha2 (10–12.5 Hz), beta1
(13–17.5 Hz) and beta2 (18–25.5 Hz) frequency bands.
Resting EEG, time domain: The EEG signal was downsampled from
1000 Hz to 256 Hz with an antialiasing ﬁlter set at 128 Hz. The ﬁltered EEG
signal was segmented into 1 s window without overlap. Curve length,
number of maxima and minima, root mean squared amplitude, Hjorth
parameters 42 (activity, mobility and complexity), zero crossings (raw
epoch, Δ, ΔΔ), autoregressive modelling error (model order 1–9), nonlinear
energy, variance (Δ, ΔΔ) were calculated using MATLAB. Mobility is an
estimate of root-mean-square frequency. Mobility = std(y(t)dy/dt)/(y(t)),
where the y(t) is the EEG amplitude at time, t.
Event-related potential: Data were divided into epochs of 300 ms
duration (200 to 500 ms post-oddball stimulus). Following a linear
detrend and a baseline correction, data were visually examined for any
artefacts and these were removed. Oddball epochs were averaged, and a
band pass ﬁlter and further baseline correction were applied. The peak
frequency was identiﬁed between 200 ms and 500 ms post-oddball for
the P300.
Sample analysis
Salivary cortisol was analysed using Enzo Life Sciences (Exeter, UK)
enzyme-linked immunosorbent assay (ELISA) kits (Catalogue no: ADI-901-
071) according to manufacturer’s instructions. Lower limit of detection=
0.16 nmol l− 1. Inter and intra-assay coefﬁcients of variability were 11.24%
and 8.2%, respectively.
Statistical analysis
Data were analysed using SPSS 21 (IBM, Armonk, NY, USA). Repeated
measures analysis of variance and t-tests (two-sided) were used to examine
differences between conditions, and non-parametric equivalents (Fried-
man and Wilcoxon, respectively) were used where parametric assumptions
were violated. Areas under the curve with respect to ground (AUCg) were
also calculated,43 and analysed in the same manner. EEG data for three
participants were removed (two had excessive levels of artefacts and one
participant suffered a tension headache when the EEG equipment was
attached). Daily questionnaire data for three participants were removed
due to lack of response to online questionnaires.
RESULTS
Acute stress response to socially evaluated cold pressor test
The stressor signiﬁcantly increased salivary cortisol at all visits.
Salivary cortisol was signiﬁcant elevated at its peak (30 min
following onset of stress) compared with immediately pre-stress
(time 0) for all three conditions (visit one: T= 5, Po0.001, r= 0.8,
post-placebo: T= 4.67, Po0.001, r= 0.78, post-1714: T= 2,
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-20 -10 0 10 20 30 40 50 60 70 80
2
4
6
8
10
12
Visit 1
Placebo
1714
**
S
T
R
E
S
S
Time (minutes)
Sa
liv
ar
y 
C
or
tis
ol
(n
M
ol
/l)
AUCg
Vis
it 1
Pla
ce
bo
17
14
0
100
200
300
400 *
*
Ar
ea
 u
nd
er
 th
e 
cu
rv
e
AUCi
Vis
it 1
Pla
ce
bo
Pr
ob
iot
ic
-50
0
50
100
150
Ar
ea
 u
nd
er
 th
e 
cu
rv
e
Visit 1
Pre-Stress Post-Stress
20
25
30
35
40
*
An
xi
et
y
Placebo
Pre-Stress Post-Stress
20
25
30
35
40
*
An
xi
et
y
1714
Pre-Stress Post-Stress
20
25
30
35
40
An
xi
et
y
Figure 1. The socially evaluated cold pressor test (SECPT) elevated cortisol, and cortisol output and the increase in anxiety were reduced post-
1714. (a) Salivary cortisol during socially evaluated cold pressor for each visit. (b) Total cortisol output for each visit, as measured by area under
the curve with respect to ground (AUCg) and area under the curve with respect to increase (AUCi). (c) State anxiety (STAI) pre- and post-
stressor at each visit. Lower scores indicate lower subjective anxiety. Error bars represent the s.e.m. *Po0.05, **Po0.001. HPA, hypothalamic-
pituitary-adrenal.
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Po0.001, r = 0.94), but there was not an interaction between
probiotic condition and stressor time point, F(1.86, 37.11) = 1.81,
P= 0.18 (Greenhouse-Geisser adjusted; Figure 1a). Nonetheless,
total cortisol output, as measured by AUCg, was signiﬁcantly
affected by probiotic condition, χ2(2) = 8.67, Po0.05, although
area under the curve with respect to increase (AUCi) was not
affected, χ2(2) = 3.71, P40.05 (Figure 1b). For AUCg, cortisol output
was lower post-1714, both compared with the post-placebo,
T= 10.69, P= 0.05, r= 0.42, and compared with the ﬁrst visit,
T= 10.94, Po0.05, r= 0.45.
There was a main effect of stressor on reported state anxiety, F
(1, 21) = 6.39, P= 0.02. State anxiety was signiﬁcantly elevated
post-stressor at both visit one, T= 8.58, Po0.05, r= 0.43, and post-
placebo, T= 7.7, Po0.01, r= 0.57. However, this was not the case
post-1714, T= 9.13, P40.05, r= 0.12 (Figure 1c). The mean time
participants kept their hand in the water was M= 157.5 s, s.d. =
47.3 for visit 1, M= 167.7, s.d. = 39.5 post-placebo and M= 170.2,
s.d. = 38 post-1714.
Reported daily stress and bowel satisfaction
Daily stress levels were broadly similar in both conditions during
their ﬁrst week, but became marginally lower in the 1714
condition by week 4, t(18) = 1.95, P= 0.07, Cohen’s d= 0.44.
Further, stress levels returned to a higher level during the
2-week follow-up period (Figure 2a). Overall stress, as measured
with AUCg, was signiﬁcantly lower during the 1714 condition
compared with the placebo, t(18) = 2.32, P= 0.03, Cohen’s d= 0.53,
and AUCi was lower in the 1714 condition, although this was not
statistically signiﬁcant, t(18) = 1.44, P40.05, Cohen’s d= 0.33
(Figure 2b). There was reduced AUCg and AUCi for bowel
satisfaction in the 1714 condition (Supplementary Figures 2A
and B), due to a brief, non-signiﬁcant reduction in reported bowel
habit satisfaction at week 2 of the 1714 condition, but this did not
persist (Supplementary Figure 2C).
Neurocognitive performance
Total errors on the paired associate learning task were signi-
ﬁcantly affected by condition, χ2(2) = 10.46, Po0.01. Compared
with the ﬁrst visit, participants made fewer errors on the
paired associate learning test both at post-placebo, (T= 7.5,
Po0.05, r= 0.5) and post-1714, (T = 6.63, Po0.01, r= 0.59), a
subtle effect at post-1714 that was greater than the placebo
response (Figure 3). See Supplementary Table 3 for full details of
results.
EEG
Fz mobility differed signiﬁcantly across conditions, χ2(2) = 13.37,
P= 0.01 (see Figures 4a for electrode positions). Mobility was
signiﬁcantly higher post-1714 compared with both post-probiotic,
T= 37, P= 0.02, r= 0.31 and visit one, T= 39, P= 0.02, r= 0.3
(Figure 4b). Cz theta power differed signiﬁcantly across 1714
conditions, χ2(2) = 10.31, Po0.01. Cz theta power was signiﬁcantly
lower post-1714 compared with post-placebo, T= 8, Po0.05,
r= 0.57, although theta power at post-1714 did not differ from
visit one (Figure 4c). There was no impact of 1714 on P300 latency
or amplitude (Supplementary Figure 3).
DISCUSSION
The current research indicates that a putative psychobiotic, the B.
longum 1714 strain, which has shown anti-stress and procognitive
effects in healthy mice19,20 can also ameliorate both the
physiological and psychological response to an acute stressor, as
well as longer-term daily self-reported psychological stress, in
healthy human adults. Furthermore, there was a subtle improve-
ment over placebo in visuospatial memory performance post-
psychobiotic, as well as an EEG proﬁle consistent with improved
memory. Whereas previous studies in healthy humans have often
examined probiotic cocktails, we believe this is the ﬁrst study to
examine the effect of a single psychobiotic strain upon a wide
range of stress outcomes and neurocognitive evaluations
informed by a preclinical screening platform.19,20 We employed
a repeated measures design to control for potential effects of
individual differences, with carefully selected cognitive and stress
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challenges that are not associated with habituation over repeated
testing within this timeframe.
Following the psychobiotic intervention, cortisol output during
the SECPT was lower, and the increase in self-reported anxiety was
no longer signiﬁcant. Interestingly, in our prior animal studies we
also showed there was a blunted physiological response to stress,
albeit manifested as a reduction in stress-induced hyperthermia,
without any alteration in corticosterone output.19 This difference
highlights the challenges in translating the ﬁndings from animal
studies to human populations and reinforces the need for multiple
stress and behavioural readouts in preclinical screening platforms.
The psychobiotic effect on the acute stress response is
complemented by a reduction in daily perceived stress that is
consistent with previous ﬁndings that a probiotic intervention can
affect subjective everyday stress.5
The subtle improvement in visuospatial memory following
probiotic administration is consistent with preclinical ﬁndings of
enhanced learning and memory in response to this strain.20 This
cognitive effect was further supported by the observation of
enhanced frontal midline (Fz) mobility using EEG. Activity at Fz is
representative of prefrontal cortex activity,44 and the prefrontal
cortex is associated with paired associate learning.23 As prefrontal
activity appears to be speciﬁcally associated with top–down
processing during associative memory,23 the current EEG ﬁndings
thus offer a potential insight into the timing of cognitive processes
underlying the observed changes in paired associate performance,
by suggesting that the impact of the psychobiotic on cognitive
performance may be due to an effect on top–down processing,
rather than simply affecting retention. Mobility has previously
been shown to be higher in healthy controls compared with
patients with Alzheimer’s disease,45 a neurodegenerative disorder
with pronounced and progressive memory deﬁcits.46 Although
Alzheimer’s disease is a severe clinical condition, it is worth noting
that the observed effects in Alzheimer’s patients were stronger
frontocentrally, which is where the change in mobility was
observed post-psychobiotic. The reduction in theta power post-
psychobiotic compared with post-placebo is also consistent with
improved memory performance.47
Further research is warranted to further elucidate mechanisms
by which the 1714 strain could impact upon stress and
neurocognition. It is possible that the reduction in daily stress
and acute stress response may account for the observed effect on
visuospatial memory. PAL test performance is dependent upon
the hippocampus,31,48 which has a high proportion of glucocorti-
coid receptors,49 and PAL test performance is poorer in subjects
with stress-related disorders with associated hypothalamic–
pituitary–adrenal axis dysfunction, such as IBS.13 B. longum
NCC3001 enhanced hippocampal brain-derived neurotrophic
factor messenger RNA and reduced anxiety-like behavior in mice
infected with the non-invasive parasite T Muris50 and B. breve 6330
increased brain-derived neurotrophic factor total variants in
healthy rats.51 It is thus of interest whether brain-derived
neurotrophic factor levels and neurogenesis are heightened in
humans following psychobiotic ingestion, thus having a key role
in the impact of psychobiotic consumption upon the central
nervous system. Furthermore, given previous evidence that
psychobiotic effects in rodents were dependent upon the vagus
nerve,7 it is possible that vagal activity may mediate such
psychobiotic effects. However, strain-speciﬁc mechanisms are
likely and need to be investigated on a case by case basis.
These results provide the impetus for further evaluation of this
psychobiotic in pathological conditions. This could initially target
stress-related brain–gut axis disorders with a cognitive component
such as IBS, which has been found to be associated with a deﬁcit
in visuospatial memory performance, evident in PAL test
performance,12,13 and we have shown PAL performance to be
subtly improved by the 1714 strain. Furthermore, the observed
psychological effects of psychobiotics warrant research in other
stress-related disorders including depression and anxiety.
In line with the predicted impact from preclinical research in
this speciﬁc strain, the 1714 strain is a promising candidate
psychobiotic strain associated with attenuated responses to
psychological and physiological stress and a modest improvement
over placebo in cognitive performance, as well as with altered
resting EEG output in healthy volunteers. Further studies are
warranted to evaluate the beneﬁts of this putative psychobiotic in
relevant stress-related conditions and to unravel the mechanisms
underlying such effects.
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